Dan Lennon is a partner in the Washington, D.C. office of Latham & Watkins and is the global Chair of the firm’s Corporate Department. He represents clients in domestic and international mergers, acquisitions, dispositions, joint ventures and financing transactions and has particular expertise in representing private equity firms and their portfolio companies in connection with all aspects of their business, including leveraged buyouts and other private equity investment transactions and related financings.
Mr. Lennon's clients include:
- The Carlyle Group
- Onex Partners
- Platinum Equity
- HCR ManorCare
- Allison Transmission
Chambers Global and Chambers USA consistently rank Mr. Lennon highly and note that he "knows what he's doing and things get done properly." Mr. Lennon is recognized as one of the nation's top private equity buyouts lawyers in The Legal 500 US 2011-2014. He is recommended for his work in mergers and acquisitions in the 2014 edition.
He was also commended in IFLR1000 2008 as a leading private equity lawyer and was noted as "highly recommended" in the M&A area in Which Lawyers Yearbook 2009. Additionally, he has been named one of the top transactional lawyers in Washington, D.C. by Super Lawyers, the Legal Times and the Washington Business Journal.
Mr. Lennon's representative transactions include advising:
- The Carlyle Group and Hellman & Friedman in connection with their US$4 billion leveraged buyout of Pharmaceutical Product Development, Inc.
- Groupo Qualicorp SA in connection with its 2011 initial public offering
- The Carlyle Group in the formation and funding of Greater China Intermodal, a joint venture formed by Carlyle, Seaspan Corporation and Tiger Group Investments for the purpose of making more than US$5 billion of container shipping investments in the greater China region
- The Carlyle Group and Onex Corporation in connection with their US$5.6 billion acquisition of Allison Transmission from General Motors
- MultiPlan, Inc. in connection with its US$3.1 billion sale to BC Partners and Silverlake
- The Carlyle Group in connection with Carlyle’s US$6.3 billion leveraged buyout of Manor Care, Inc.